• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 766

3'-sialyllactose sodium salt

Intended Use: For use as an ingredient in non-exempt term infant formula at a maximum level of 238 mg/L as consumed. Also for use as an ingredient in dairy product analogs, infant and toddler foods, milk (whole and skim), milk products, grain products, beverages and beverages bases, and sugar substitutes at levels ranging from 24 to 3000 mg/RACC.
Basis: Scientific procedures
Notifier: GeneChem, Inc.
Notifier Address: Migun Techno World II
A-201, 187 Techno 2-ro
Yuseong-gu, 34025, Daejeon
Republic of Korea
GRAS Notice (releasable information): GRN 766 with amendments (in PDF) (14 MB)
Date of closure: Sep 26, 2018
Date of FDA’s corrected letter: May 7, 2019
FDA's Letter: FDA has no questions (in PDF) (920 kB)